Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brain Autoregulation Research Study

NCT: NCT07221721 · WITHDRAWN

NCT IDNCT07221721
StatusWITHDRAWN
Start Date2026-06
Completion2028-12
SponsorJennie E Minnich (OTHER)
First posted
Last updated

Brief Summary

Randomized, multi-site, study assessing the feasibility of lower limit of autoregulation targeted mean arterial pressure (MAP) vs. standard MAP management in neonates undergoing cardiac surgery with cardiopulmonary bypass. After eligibility screening and consent, subjects will be randomized to either the intervention (study) or control group.

Frequently Asked Questions

What is Brain Autoregulation Research Study?

Brain Autoregulation Research Study is a clinical trial registered under NCT07221721. Current status: WITHDRAWN.

What is the status of NCT07221721?

The current status of NCT07221721 (Brain Autoregulation Research Study) is: WITHDRAWN.

When did Brain Autoregulation Research Study start?

Brain Autoregulation Research Study started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑